Marc Viscogliosi is the founder of Spine BioPharma. Spine BioPharma has raised $13M in total funding. Latest round: Series B. Based in New York, NY.
Marc Viscogliosi is the Founder, Chair, and CEO of Spine BioPharma. The company, established in 2015, focuses on developing non-opiate, non-surgical therapies for chronic low back pain. He is also an investor in the company through Viscogliosi Bros., LLC.
Full founder directory · Investor directory · Company funding database · Fundraising library